These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15857456)

  • 1. Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin.
    Brown MB; Jones SA
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):308-18. PubMed ID: 15857456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan: pharmaceutical characterization and drug delivery.
    Liao YH; Jones SA; Forbes B; Martin GP; Brown MB
    Drug Deliv; 2005; 12(6):327-42. PubMed ID: 16253949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects.
    Weindl G; Schaller M; Schäfer-Korting M; Korting HC
    Skin Pharmacol Physiol; 2004; 17(5):207-13. PubMed ID: 15452406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
    Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical applications of hyaluronic acid].
    Galus R; Antiszko M; Włodarski P
    Pol Merkur Lekarski; 2006 May; 20(119):606-8. PubMed ID: 16875173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hyaluronan on the in vitro deposition of diclofenac within the skin.
    Brown MB; Marriott C; Martin GP
    Int J Tissue React; 1995; 17(4):133-40. PubMed ID: 8867643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications.
    Kogan G; Soltés L; Stern R; Gemeiner P
    Biotechnol Lett; 2007 Jan; 29(1):17-25. PubMed ID: 17091377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply: hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin.
    Chandrashekar L
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1348-9. PubMed ID: 17062068
    [No Abstract]   [Full Text] [Related]  

  • 9. 3% diclofenac in 2.5% hyaluronic acid (Solaraze) does not induce photosensitivity or phototoxicity alone or in combination with sunscreens.
    Ortonne JP; Queille-Roussel C; Duteil L
    Eur J Dermatol; 2006; 16(4):385-90. PubMed ID: 16935795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory vs. inflammatory treatments for actinic keratoses.
    Ortonne JP
    J Cosmet Dermatol; 2003 Jul; 2(3-4):135-40. PubMed ID: 17163919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of hyaluronan and its ophthalmic applications.
    Rah MJ
    Optometry; 2011 Jan; 82(1):38-43. PubMed ID: 21146792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses.
    Rivers JK
    Skin Therapy Lett; 2004 Jan; 9(1):1-3. PubMed ID: 14716439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An insight on hyaluronic acid in drug targeting and drug delivery.
    Yadav AK; Mishra P; Agrawal GP
    J Drug Target; 2008 Feb; 16(2):91-107. PubMed ID: 18274931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs.
    Brown MB; Hanpanitcharoen M; Martin GP
    Int J Pharm; 2001 Aug; 225(1-2):113-21. PubMed ID: 11489559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
    Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
    J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of MeroGel hyaluronic acid on tympanic membrane perforations.
    Ozturk K; Yaman H; Cihat Avunduk M; Arbag H; Keles B; Uyar Y
    Acta Otolaryngol; 2006 Dec; 126(11):1158-63. PubMed ID: 17050307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of topical 0.2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behçet's disease.
    Lee JH; Jung JY; Bang D
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):590-5. PubMed ID: 18093111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current research on hyaluronic acid-drug bioconjugates.
    Zhang H; Huang S; Yang X; Zhai G
    Eur J Med Chem; 2014 Oct; 86():310-7. PubMed ID: 25173850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.